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INTRODUCTION
 Non-communicable diseases (NCDs) and 
their risk factors have emerged as one of the 
major health problems globally.1 A significant 
contributor to NCD mortality is cardiovascular 
diseases; most notably acute coronary syndrome 
(ACS).2 Cardiovascular disease incidence and 
mortality are falling in high-income countries. 
Still, in contrast, they are rising in low and middle-
income countries where they now account for 
nearly half of the disease burden.3
 ACS has a significant impact on patients’ physical 
and psychological well-being, contributing to the 
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ABSTRACT
Objectives: To determine the effectiveness of mobile health augmented cardiac rehabilitation (MCard) on 
health-related quality of life (HRQoL), clinical and behavioural outcomes in post-ACS. 
Methods: A single-centre, single-blinded, two-arm randomised controlled trial is planned at Armed 
Forces Institute of Cardiology (AFIC), Pakistan. The duration was two years, that is from January 2019 till 
December 2020. A total of 160 participants were recruited and randomly allocated to the control group 
or the intervention group. Intervention is a mobile health augmented cardiac rehabilitation (MCard), a 
medically supervised cardiac rehabilitation program for 23-24 weeks. The phase one includes individual 
counselling during the hospital stay and in phase two includes communication of standardised messages 
related to healthy lifestyle modification through a specifically designed software.
Results: This clinical trial results will give  insight into the impact of MCard in improving the health 
outcomes (HRQoL, clinical and behavioural) of participants. If proven to be effective, this technology can 
be scaled up and implemented in other cardiac centres in the country. It utilises fewer human resources 
and can be delivered at a lower cost.
Conclusion: The study protocol will be giving evidence either MCard can contribute to improving the 
HRQoL, clinical and behavioural outcomes of post-ACS patients following hospital discharge. Considering 
the COVID-9 situation, this is the perfect time to implement and evaluate the effectiveness of MCard on 
health outcomes among post-ACS patients. 
KEYWORDS: Acute coronary syndrome, Cardiac rehabilitation, Communication, Health-related quality of 
life, Mhealth, Mobile health, Randomised controlled trial, Rehabilitation, Text messages.
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deterioration of their health-related quality of life 
(HRQoL). Impaired HRQoL leads to poor health 
outcomes in the form of morbidity or mortality.4 
Cardiac rehabilitation has been adopted in the 
cardiac institute to deal with post-ACS patients’ 
physical and mental well-being. Many clinical 
studies5,6 has proven the effectiveness of cardiac 
rehabilitation. Still, access, acceptability and 
affordability to these cardiac rehabilitation 
programs are limited with overall participation 
between 20 per cent to 50 per cent only.
 Comprehensive cardiac rehabilitation programs 
as secondary preventive measures involving 
personalised counselling sessions, behaviour 
change modification, and empowering patients 
with self-monitoring devices can reduce the ACS 
associated with premature mortality, morbidity, 
and healthcare costs.7 
 Novel ways8 are now being explored to improve 
the provision and uptake of cardiac rehabilitation. 
Mobile technology provides affordable access 
to many patients at low cost and without travel 
and distance constraints. Therefore, there is a 
growing interest in its potential role in health 
promotion for modifiable risk factors prevalent 
in ACS patients.
 A clinical trial has been devised to implement 
a telecommunication based cardiac rehabilitation 
in which participants will be  encouraged for 
self-care. Suppose this intervention proved to be 
effective in terms of bringing a change in their 
HRQoL, behavioural and clinical outcomes, then 
in coming years. In that case, mhealth technology 
could be a convenient and effective way of 
communicating health messages to post-ACS 
patients in health care settings.
METHODS
 This clinical trial’s study objective was to assess 
a cardiac rehabilitation program’s effectiveness 
in which text messages to post-acute coronary 
syndrome (post-ACS) patients related to healthy 
lifestyle modification will be communicated. The 
objectives was  as follows:
1. To determine the effectiveness of MCard on 
HRQoL outcomes in post-ACS patients. 
2. To determine the effectiveness of MCard on 
clinical outcomes in post-ACS patients. 
3. To determine the effectiveness of MCard on 
behavioural outcomes in post-ACS patients. 
4. To determine the acceptability of the MCard 
among post-ACS patients. 
 We hypothesised that post-ACS patients 
who receive the interventions would positively 
impact their health outcomes (HRQoL, clinical 
and behavioural) compared to those who receive 
the usual care. This paper is written per the 
Standard Protocol Items: Recommendations for 
Interventional Trials (SPIRIT) 2013 statement. The 
trial will be registered in line with CONSORT 
2010 Statement: updated guidelines for parallel 
reporting group randomised trials. The detail 
of participants enrollment with a trial schedule 
is described through the Table-I and the SPIRIT 
checklist is attached as supplementary file 1.
 This was a single-centre, single-blinded, two-
arm randomised controlled trial conducted 
at Armed Forces Institute of Cardiology 
(AFIC). The clinical trial was registered with 
the Australian New Zealand Clinical Trials 
Registry (ANZCTR) under trial identity number 
ACTRN12619001731189.9
 The total study duration will be approximately 
two years from January 2019 till December 2020. 
After analysing hospital data, it is expected that 
patient recruitment will take approximately 16-
20 weeks (at least 10-12 patients per week) while 
intervention will take 23-24 weeks. 
 The patient coming to AFIC emergency and 
admitted in its wards with ACS diagnosis with 
ACS will be enrolled in this clinical trial after 
fulfilling the eligibility criteria as in Table-II. 
ACS will be diagnosed by at least one on-call 
cardiologist (cardiac consultant) based on the 
chest or epigastric pain, radiating to the arm, 
jaw, neck or back), cardiac markers ((Creatine 
phosphokinase and/or creatine kinase-MB and/
or Troponin I)) and/or electrocardiogram (ST 
elevation or non-ST elevation). 
 The primary outcome measure that is HRQoL 
physical component summary was used for 
sample size estimation in STATA version 14. A 
sample size of 61 per group in a ratio of 1:1 was 
calculated by two independent mean tests of 
SF-36 physical component (control group; 39.09 
and intervention group 42.65),10 assuming SF-36 
physical component variability of 6.74 and 7.14 
in control and intervention group respectively, 
a power of 80% and a significance level of 5%. 
To allow for a predicted 25% drop-out or lost to 
follow-up rate from adverse events, the sample 
size has been increased to 80 per group, recruiting 
160 participants (80 x 2=160) altogether.
 After recruitment into the clinical trial, the 
baseline information will be  recorded by a data 
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collector. The data collector will be blinded to the 
participant’s actual trial arm before and after the 
intervention. The random assignment of recruited 
participants into the two arms was performed by 
a research associate using web-based permuted 
block randomisation (4 x 8), ensuring 1:1 ratio 
between the two arms (i.e. 80 in each). Allocation 
concealment will be  conducted by the sequentially 
numbered opaque sealed envelope.
 The data collector will be communicating with 
the participants (intervention and control group) 
for the follow-up data collection at 12 weeks and 
24 weeks. Participants will be requested not to 
disclose their counselling session or text message 
communication to the data collector. At 12 and 24 
weeks, the participants will be asked for a follow-
up to the hospital. If the patient cannot come for 
follow-up, the information will be collected via 
telephone interview within the ± 01 week period 
of 12 or 24 weeks.
Intervention Group: MCard will be a medically 
supervised cardiac rehabilitation program for a 
total period of 23-24 weeks for the intervention 
group. The Phase-I will be initiated during the 
hospital stay and will include one individual 
face to face behavioural change modification 
counselling using HEARTS, a technical package 
for cardiovascular disease management by the 
World Health Organization.11 Phase-II will be 
initiated after hospital discharge. The intervention 
details are devised in line with Tidier guidelines12 
and are attached as supplementary file 2. The 
details of the groups are described in Table-III.
 The core component of the MCard is that the 
participants will receive the same standardised 
messages on their mobile phones related 
to healthy lifestyle modification through a 
specifically designed software. This will be two-
way communication in which the patient will 
receive text messages and inquire info through 
texting back. A health professional (principal 
investigator) and/or an associate researcher 
will be receiving the calls and messages from the 
patients and respond to them. The mobile text 
Cardiac Rehabilitation effectiveness after Myocardial Infarction
Table-I: Schedule of enrollment, intervention and assessment of 
recruited participants according to SPIRIT 2013.
Study Period (In weeks)
Enrolment Baseline Allocation Post-allocation













Basic Demographic Variables X
HRQoL
(MacNew QMLI & SF-12)
X X X
Clinical Outcomes X X X
Behavioural Outcomes X X X
Adherence X
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messages will be the same for all the intervention 
group. Manually one message per day will be 
communicated to group B for 23-24 weeks. The 
principal investigator will communicate a total of 
161-168 messages through the MCard designed 
software. The health messages have been devised 
by first having a small group discussion with 
patients to identify the gap in knowledge related 
to modifiable risk factors (physical inactivity, 
unhealthy diet, salt intake, tobacco use and 
medicine defiance). The devised messages were 
rephrased for communication after having a 
consultation with a cardiologist. Rephrasing of the 
messages was conducted for easy understanding 
of the participants.
Control Group: The control group received 
standard care. However, they did not receive text 
messages on their mobile related to healthy lifestyle 
modifications. 
Self-monitoring devices and brochure: The 
standard post-ACS care and self-monitoring 
devices (digital blood pressure machine, 
digital weight machine and a pedometer) 
was provided to all patients of both arms to 
determine the actual impact of health messages 
communication. All the participants will be 
briefed on how to use the above three devices. 
They will be made practically aware of how 
and when to use these devices. Participants 
will be asked to fill in the brochure their blood 
pressure and early morning empty stomach 
body weight once in a week while steps taken 
shall be recorded daily at the end of the day 
before they go to sleep.
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(n=80, control) √ √
Group B
(n=80, intervention) √ √ √ √
Table-II: Inclusion and exclusion criteria for MCard.
Inclusion criteria Exclusion criteria 
i. Age eligibility: From 35 years till 65 years.
ii. Gender eligibility: Both
iii. Diagnosed with documented ACS evidence by a 
cardiologist based on the chest or epigastric pain, 
radiating to the arm, jaw, neck or back and/or 
cardiac markers and/or electrocardiogram.
iv. Ejection fraction of >25%.
v. Patients are having mobile phone ownership or 
a caretaker who can assist in handling mobile.
vi. Patients are giving fully informed voluntary 
written consent for participation. 
vii. The patient may only have received medical 
treatment or may have undergone cardiac 
revascularisation procedure percutaneous 
coronary intervention or thrombolytic 
therapy. 
i. Mini-mental State Examination of less than 24. 
ii. Not physically or mentally capable of handling a 
mobile phone.
iii. Diagnosed with familial hypercholesterolemia.
iv. History of cerebrovascular accident.
v. Patient on hemodialysis or peritoneal dialysis.
vi. A patient diagnosed with hepatitis B or C by 
          serology.
vii. Concurrent severe disease, such as malignancy.
viii. Is or may be pregnant.
 A trained research associate will assess 
participants three times during the whole study 
period that is 23-24 weeks first at baseline before 
they are discharged from hospital after taking 
informed written consent. Then at 12 weeks, 
at the follow-up period and then at 24 weeks 
post-discharge. In case follow-up is missed or 
is not undertaken, the telephonic interview will 
be undertaken. The participant’s demographic 
questionnaire will be inquired, including 
information regarding age, gender, educational 
status, medical history, income per month, the 
preferred medium of text communication, and 
behavioural and clinical parameters. At the end 
of the 24th week, along with other information, 
the MCard program’s subjective acceptability 
will also be evaluated on a Likert scale.
Primary Outcome is HRQoL:13 It is a 
multidimensional concept that describes individuals 
or groups’ perceived physical and mental health 
over some time. The primary outcome changes 
in HRQoL which will be assessed by validated 
disease-specific (MacNew quality of life after 
myocardial infarction (MacNew QLMI) form)14 and 
generic instruments (Short Form 12 (SF-12)).15
Secondary Outcomes: 
a. Clinical Outcomes: Clinical outcomes are 
quantifiable changes in physical health as 
a result of health care interventions. In this 
randomised control trial, the following clinical 
outcomes will be recorded: 
i. Physiological parameters:
* Blood pressure measurement (systolic and 
diastolic in millimetres of mercury) will be taken 
according to the Centers for Disease Control 
and Prevention. 
* Body mass index measurement will be derived 
from weight in kilogram divided by height in 
meters squared. 
ii. The number of days of current hospitalisation at 
12 and 24 weeks if any.
iii. Number of readmissions to the hospital within 
180 days after ACS date.
iv. Major adverse cardiovascular events (MACE): 
After hospital discharge, if patients come to the 
hospital with repeat-MI, heart failure, symptom-
driven coronary revascularisation or death, they 
will be identified as having a MACE. 
b. Behavioural outcomes: It refers to the end 
result of action to improve their health. The 
following patient behavioural outcomes will 
be assessed on the subjective basis within the 
last four weeks:
i. Self-monitoring (systolic and diastolic blood 
pressure in millimetres of mercury and body 
weight in kilogram at least once weekly)
ii. Number of steps taken per day measured by 
pedometer (Physical activity)
iii. Medicine compliance: Taking medicines 
according to their cardiologist prescription. 
iv. Salt restriction: Subjective patient salt intake 
will be recorded. They will be asked if they 
think they are taking less than one teaspoon per 
day in all food. 
v. Smoking status (no smoker, current smoker or 
ex-smoker): Smoking status of the patient’s last 
month will be recorded. 
vi. Healthy diet preferences: Subjective patient 
healthy diet will be recorded. They will be 
asked what type of food they prefer. Are they 
following the recommended diet? 
vii. Acceptability: At the end of the clinical trial, at 
24 weeks, the post-ACS patient will be asked 
to judge the program acceptability on a Likert 
scale from 1 to 5, 1 being unacceptable and 5 
being acceptable. 
 Data will be entered and analysed in STATA 
version 14 using the intention to treat principle. 
Descriptive data will be presented as frequency and 
percentages. Continuous data will be presented 
by means with their 95% confidence intervals. 
Table and graphs will be constructed for reporting 
sociodemographic, behavioural and clinical data. 
Age, gender, education level, comorbidity will be 
included as potential covariates. All of the analyses 
will be taken statistically significant at a two-tailed 
p-value of < 0.05.
Ethics approval and consent to participate: The 
Ethical Review Committee of Khyber Medical 
University (DIR/KMU-EB/MH/000486) and 
Armed Forces Institute of Cardiology (AFIC-
IERB-SOP-15) has approved the clinical trial 
protocol and its amendments before the start of 
the study. Written informed consent was taken 
from each participant before enrolling them.
RESULT
 Ethical and institutional permission has been 
sought. Research associate has been hired, and 
their training is also completed. Participants 
recruitment has been planned, and the primary 
data completion date is December 2020. After 
that, the results will be analysed and expected 
to be published within three months of work 
completion. 
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DISCUSSION
 Pakistan is a resource-constrained country 
whose health care system faces the triple burden 
of diseases (i.e. communicable diseases, non-
communicable disease and injuries). Our health 
care system is a vulnerable one and is trying 
to deal with this emerging burden of NCDs 
precisely the increasing burden of cardiovascular 
disease.16 Tobacco, physical inactivity, unhealthy 
diet are the modifiable risk factors which if are 
not controlled in post-ACS patients, increases 
their risk of re-infraction along with increased 
mortality and morbidity.17,18
 A comprehensive preventive intervention that 
is adopted by many developed countries for 
coronary artery diseases is cardiac rehabilitation. 
The primary purpose of the cardiac rehabilitation 
programs is to maximise patients’ physical 
functionality, improve their quality of life, and 
prevent the recurrence of major cardiovascular 
and cerebrovascular events.19 
 Clinical guidelines strongly recommend that 
patients have access to a cardiac rehabilitation 
program, and there is strong scientific evidence 
of its effectiveness. However, globally, the overall 
participation in these cardiac rehabilitation 
programs ranges only between 20 per cent to 50 
per cent.14 In these cardiac rehabilitation studies,20 
HRQoL is often used as an outcome measure 
and is a known predictor of post-ACS patient’s 
morbidity and mortality. 
 Studies21-23 conducted in developed and 
developing countries targeting mobile health 
communication having different intervention 
period starting from one month to two years with 
averaging six months duration. In developed 
countries, websites, mobile application, and 
other smart communication have been created to 
incorporate mhealth into health care setup. 
 The MCard is one of the first clinical trials 
conducted in Pakistan, which has incorporated 
two-way communication using mobile 
technology modifiable risk factors to impact post-
ACS patients’ outcomes, i.e. HRQoL, clinical and 
behaviour. One of the study limitations is that it 
is a single centred study, if further studies are to 
be planed, they shall be multi-centred as it would 
be portraying a wider picture od the trial.
CONCLUSION
 There has not been a single randomised 
controlled trial conducted in Pakistan, which 
involved mobile health communication in 
cardiac rehabilitation. Considering the COVID-9 
situation, this is the perfect time to implement 
and evaluate the effectiveness of MCard on health 
outcomes among post-ACS patients.
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